Diagnosis of idiopathic growth hormone deficiency: Contributions of data on the acid-labile subunit, insulin-like growth factor (IGF)-I and II, and IGF binding protein-3

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 4, 2006, Pages 481-489

  Trivin, Christine ^a   Souberbielle, Jean Claude ^a   Aubertin, Guillaume ^b   Lawson Body, Ethel ^a   Adan, Luis ^b,c   Brauner, Raja ^b,d  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^d NONE   (France)

Author keywords

Acid labile subunit; Growth; Growth hormone deficiency; Insulin like binding protein 3; Insulin like growth factor; Magnetic resonance imaging; Short stature

Indexed keywords

BIOLOGICAL MARKER; GROWTH HORMONE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ARTICLE; CHILD; CHILD GROWTH; CONTROLLED STUDY; DISEASE CLASSIFICATION; FEMALE; GROWTH HORMONE DEFICIENCY; GROWTH RATE; HORMONAL REGULATION; HORMONE DETERMINATION; HORMONE SENSITIVITY; HUMAN; IDIOPATHIC DISEASE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PREPUBERTY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SCORING SYSTEM; SHORT STATURE; STATISTICAL SIGNIFICANCE;

BODY HEIGHT; CARRIER PROTEINS; CHILD; CHILD, PRESCHOOL; DWARFISM, PITUITARY; FEMALE; GLYCOPROTEINS; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; PROTEINS; RETROSPECTIVE STUDIES; STATISTICS;

EID: 33646834637     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Wyatt DT. Ad hoc Committee for Standardization of Growth Hormone Assays. J Clin Endocrinol Metab 1995; 80: 3389-3390.
2. Sizonenko PC, Clayton PE, Cohen P, Hintz RL, Tanaka T, Laron Z. Diagnosis and management of growth hormone deficiency in childhood and adolescence Part 1: Diagnosis of growth hormone deficiency. GH IGF Res 2001; 11: 137-165.
3. Rosenfeld RG, Albertsson-Wikland K, Cassorla F, Frasier SD, Hasegawa Y, Hintz RL, LaFranchi S, Lippe B, Loriaux L, Melmed S, Preece MA, Ranke MB, Reiter EO, Rogol AD, Underwood LE, Werther GA. Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab 1995; 80: 1532-1540.
4. Zadik Z, Chalew SA, Gilula Z, Kowarski AA. Reproducibility of growth hormone testing procedures: a comparison between 24-hour integrated concentration and pharmacological stimulation. J Clin Endocrinol Metab 1990; 71: 1127-1130.
5. Celniker AC, Chen AB, Wert RM Jr, Sherman BM. Variability in the quantitation of circulating growth hormone using commercial immunoassays. J Clin Endocrinol Metab 1989; 68: 469-476.
6. Ghigo E, Bellone J, Aimaretti G, Bellone S, Loche S, Cappa M, Bartolotta E, Dammacco F, Camanni F. Reliability of provocative tests to assess growth hormone secretoty status. Study in 472 normally growing children. J Clin Endocrinol Metab 1996; 81: 3323-3327.
7. Rochiccioli P, Enjaume C, Tauber MT, Pienkowski C. Statistical study of 5473 results of nine pharmacological stimulation tests: a proposed weighting index. Acta Paediatr 1993; 82: 245-248.
8. Marin G, Domené HM, Barnes KM, Blackwell BJ, Cassorla FG, Cutler GB Jr. The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 1994; 79: 537-541.
9. Loche S, Cappa M, Borelli P, Faedda A, Crino A, Cella SG, Corda R, Muller EE, Pintor C. Reduced growth hormone response to growth hormone-releasing hormone in children with simple obesity: evidence for somatomedin-C mediated inhibition. Clin Endocrinol 1987; 27: 145-153.
10. Carel JC, Tresca JP, Letrait M, Chaussain JL, Lebouc Y, Job JC, Coste J. Growth hormone testing for the diagnosis of growth hormone deficiency in childhood: a population register-based study. J Clin Endocrinol Metab 1997; 82: 2117-2121.
11. Cacciari E, Tassoni P, Parisi G, Pirazzoli P, Zucchini S, Mandini M, Cicognani A, Balsamo A. Pitfalls in diagnosing impaired growth hormone (GH) secretion: retesting after replacement therapy of 63 patients defined as GH deficient. J Clin Endocrinol Metab 1992; 74: 1284-1289.
12. Juul A, Kastrup KW, Pedersen SA, Skakkebæk NE. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF I) and IGF-binding protein-3. J Clin Endocrinol Metab 1997: 82; 1195-1201.
13. Tauber M, Moulin P, Pienkowski C, Jouret B, Rochiccioli P. Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment. J Clin Endocrinol Metab 1997; 82: 352-356.
14. Castro C, Trivin C, Souberbielle JC, Zerah M, Brauner R. Growth hormone deficiency: permanence and diagnosis in young adults. Horm Res 2002; 58: 165-171.
15. Maghnie M, Strigazzi C, Tinelli C, Autelli M, Cisternino M, Loche S, Severi F. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults. J Clin Endocrinol Metab 1999; 84: 1324-1328.
16. Gandrud LM, Wilson DM. Is growth hormone stimulation testing in children still appropriate? GH IGF Res 2004; 14: 185-194.
17. Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society. J Clin Endocrinol Metab 2000; 85: 3990-3993 [reprinted in J Pediatr Endocrinol Metab 2001; 14: 377-382].
18. Smith WJ, Nam TJ, Underwood LE, Busby WH, Celnicker A, Clemmons DR. Use of insulin-like growth factor-binding protein-2 (IGFBP-2), IGFBP-3, and IGF-I for assessing growth hormone status in short children. J Clin Endocrinol Metab 1993; 77: 1294-1299.
19. Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Tsuchiya Y, Nose O, Ohyama Y, Araki K, Tanaka T, Saisyo S, et al. Comparison between insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3) measurement in the diagnosis of growth hormone deficiency. Endocr J 1993; 40: 185-190.
20. Hasegawa Y, Hasegawa T, Aso T, Kotoh S, Nose O, Ohyama Y, Arabi K, Tanaka T, Saisyo S, Yokoya S, et al. Clinical utility of insulin-like growth factor binding protein-3 in the evaluation and treatment of short children with suspected growth hormone deficiency. Eur J Endocrinol 1994; 131: 27-32.
21. Juul A, Skakkebæk NE. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. J Pediatr 1997; 130: 197-204.
22. Adan L, Souberbielle JC, Brauner R. Diagnostic markers of permanent idiopathic growth hormone deficiency. J Clin Endocrinol Metab 1994; 78: 353-358.
23. Karachaliou F, Stamoyannou L, Maravelias K, Bartsocas CS, Koutselinis A. Serum levels of IGFBP-3: usefulness in diagnosis of GH deficiency and relationship to measurements of GH secretion in children. J Pediatr Endocrinol Metab 1996; 9: 169-174.
24. Nunez SB, Municchi G, Barnes KM, Rose SR. Insulin-like growth factor I (IGF-I) and IGF-binding protein-3 concentrations compared to stimulated and night growth hormone in the evaluation of short children - a clinical research center study. J Clin Endocrinol Metab 1996; 81: 1927-1232.
25. Cianfarani S, Boemi S, Spagnoli A, Cappa M, Argiro G, Vaccaro F, Manca Bitti ML, Boscherini B. Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency? Clin Endocrinol 1995; 43: 43-47.
26. Tillmann V, Buckler JMH, Kibirige MS, Price DA, Shalet SM, Wales JKH, Addison MG, Gill MS, Whatmore AJ, Clayton PE. Biochemical tests in the diagnosis of childhood growth hormone deficiency. J Clin Endocrinol Metab 1997; 82: 531-535.
27. Rikken B, van Doorn J, Ringeling A, Van den Brande JL, Massa G, Wit JM. Plasma levels of insulin-like growth factor (IGF-I), IGF-II and IGF-binding protein-3 in the evaluation of childhood growth hormone deficiency. Horm Res 1998; 50: 166-176.
28. Mitchell H, Dattani MT, Nanduri V, Hindmarsh PC, Preece MA, Brook CGD. Failure of IGF-I and IGFBP-3 to diagnose growth hormone insufficiency. Arch Dis Child 1999; 80: 443-447.
29. Giacobbi V, Trivin C, Lawson-Body E, Fonseca M, Souberbielle JC, Brauner R. Extreme short stature: influence of each parent's height on clinical-biological features. Horm Res 2003; 60: 272-276.
30. Wieringa GE, Barth JH, Trainer PJ. Growth hormone assay standardization: a biased view? Clin Endocrinol 2004; 60: 538-539.
31. Bussières L, Souberbielle JC, Pinto G, Adan L, Noël M, Brauner R. The use of insulin like growth factor I reference values for the diagnosis of growth hormone deficiency in prepubertal children. Clin Endocrinol 2000; 52: 735-739.
32. Juul A, Moller S, Mosfeldt-Laursen E, Rasmussen MH, Scheike T, Pedersen SA, Kastrup KW, Yu H, Mistry J, Rasmussen S, Müller J, Henriksen J, Skakkebæk NE. The acid-labile subunit of human ternary insulin-like growth factor binding protein complex in serum: hepatosplanchnic release, diurnal variation, circulating concentrations in healthy subjects, and diagnostic use in patients with growth hormone deficiency. J Clin Endocrinol Metab 1998; 83: 4408-4415.
33. Rosenfeld RG, Wilson DM, Lee PDK, Hintz RL. Insulin-like growth factors I and II in evaluation of growth retardation. J Pediatr 1986; 109: 428-433.
34. Baxter RC. Editorial: The binding protein's binding protein - clinical applications of acid-labile subunit (ALS) measurement. J Clin Endocrinol Metab 1997; 82: 3941-3943.
35. Nimura A, Katsumata N, Horikawa R, Tanae A, Tanaka T. Acid-labile subunit (ALS) measurements in children. Endocr J 2000; 47: S111-114.
36. Mukherjee A, Monson JP, Jönsson PJ, Trainer PJ, Shalet SM; on behalf of the KIMS International Board. Seeking the optimal target range for insulin-like growth factor I during the treatment of adult growth hormone disorders. J Clin Endocrinol Metab 2003; 88: 5865-5870.
37. Barrios V, Argente J, Muñoz MT, Pozo J, Chowen JA, Hernández M. Diagnostic interest of acid-labile subunit measurement in relationship to other components of the IGF system in pediatric patients with growth or eating disorders. Eur J Endocrinol 2001; 144: 245-250.
38. Thorén M, Hilding A, Baxter RC, Degerblad M, Wivall-Helleryd IL, Hall K. Serum insulin-like growth factor I (IGF I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency. J Clin Endocrinol Metab 1997; 82: 223-228.